Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis

Table 2 Serum content of ALT, AST, HA and LN

Group	ALT (u/L)	AST (u/L)	HA (µg/L)	LN (µg/L)
Normal	52.5 ± 9.2a	137.8 ± 18.7a	178 ± 58a	59.8 ± 21.8a
Model	165.6 ± 32.7ace	257.4 ± 22.6c	550 ± 68c	130.0 ± 30.5c
Colchicine	96.2 ± 20.9c	215.8 ± 24.6c	416 ± 135c	106.3 ± 14.2c
AF	65.8 ± 26.5a	150.8 ± 34.0a	228 ± 83ac	85.9 ± 15.0c
AS	67.3 ± 18.4a	154.6 ± 27.3a	216 ± 58ac	80.6 ± 18.6c

^aP < 0.05, vs colchicine group;

^cP < 0.05, vs normal control group;

^eP > 0.05, vs control group.